Different growth properties in response to epidermal growth factor and interleukin-6 of primary keratinocytes derived from normal and psoriatic lesional skin

Journal of Dermatological Science

Volumn 16, Issue 2, 1998, Pages 120-128

  Oyama, Noritaka ^a   Sekimata, Masayuki ^a   Nihei, Yoshimichi ^a   Iwatsuki, Keiji ^a   Homma, Yoshimi ^a   Kaneko, Fumio ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cell growth; Epidermal growth factor receptor; Interleukin 6; Keratinocytes; Psoriasis

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 6;

ADULT; ARTICLE; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS;

EID: 0030627442     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(97)00040-6     Document Type: Article

References (40)

1. [1] Weinstein GD, McCullough JL. Cytokinetics in diseases of epidermal hyperplasia. Annu Rev Med 1973;24:345-51.
2. [2] Morganroth GS, Chan LS, Weinstein GD, Voorhees JJ, Cooper KD. Proliferating cells in psoriatic dermis are comprised primarily of T cells, endothelial cells, and factor XIIIa + perivascular dendritic cells. J Invest Dermatol 1991;96:333-40.
3. [3] Gottieb AB, Lifschitz B, Fu SM, Staiano-Coico L, Wang CY, Carter DM. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques. J Exp Med 1986;164:1013-28.
4. [4] Morhenn VB. Keratinocyte proliferation in wound healing and skin diseases. Immunol Today 1988;9:104-7.
5. [5] Nyfors A, Lemholt K. Psoriasis in children. A short review and a survey of 245 cases. Br J Dermatol 1975;92:437-42.
6. [6] Lloyd EK Jr., Ronald EG, Christa MS, Lillian BN. Epidermal growth factor/transforming growth factor alpha receptors and psoriasis. J Invest Dermatol 1990;95:10S-2S.
7. [7] Amagai M, Ozawa S, Ueda M, Nishikawa T, Abe O, Shimizu N. Distribution of EGF receptor expressing and DNA replicating epidermal cells in psoriasis vulgaris and Bowen's disease. Br J Dermatol 1988;119:661-8.
8. 125I epidermal growth factor binding and receptor distribution in psoriais. J Invest Dermatol 1986;86:260-5.
9. [9] Ansel J, Perry P, Brown J, Damm D, Phan T, Hart C, Luger T, Hefeneider S. Cytokine modulation of keratinocyte cytokines. J Invest Dermatol 1990;94:101S-7S.
10. [10] Gregory H. Isolation and structure of urogastrone and its relationship to epidermal growth factor. Nature (Lond.) 1975;257:325-7.
11. [11] Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsburn M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science (Wash. DC) 1991;251:936-9.
12. [12] Todaro GJ, Frying C, DeLarco J. Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factors. Proc Natl Acad Sci USA 1980;77:5258-62.
13. [13] Shoyab M, Plowman GD, McDonald VL, Bradley JG, Todaro GJ. Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science (Wash. DC) 1989;243:1074-6.
14. [14] Ciccodicola A, Dono R, Obici S, Simeone A, Zollo M, Perico GM. Molecular characterization of a gene of the EGF family expressed in undifferentiated human NTERA2 teratocarcinoma cells. EMBO J 1989;8:1987-91.
15. [15] Blomquist MC, Hunt LC, Barker WC. Vaccinia virus 19-kilodalton protein: Relationship to several mammalian proteins, including two growth factors. Proc Natl Acad Sci USA 1984;81:7363-7.
16. [16] Proter CD, Archard LC. Characterization and physical mapping of molluscum contagiosum virus DNA and location of a sequence capable of encoding a conserved domain of epidermal growth factor. J Gen Virol 1987;68:673-82.
17. [17] Chang W, Upton C, Hu SL, Purchio AF, McFadden G. The genome of shope fibroma virus, a tumorigenic poxvirus, contains a growth factor gene with sequence similarity of those encoding epidermal growth factor and transforming growth factor alpha. Mol Cell Biol 1987;7:535-40.
18. [18] Yamazaki H, Fukui Y, Ueyama Y, Tamaoki N, Kawamoto T, Taniguchi S, Shibuya M. Amplification of structurally and functionally altered epidermal growth factor receptor gene (erb-B) in human brain tumors. Mol Cell Biol 1988;8:1816-20.
19. [19] Groves RW, Allen MH, MacDonald DM. Abnormal expression of epidermal growth factor receptor in cutaneous epithelial tumors. J Cutaneous Pathol 1992;19:66-72.
20. [20] Sainsbury JRC, Farndon JR, Harris AL, Sherbet GV. Epidermal growth factor receptors on human breast cancers. Br J Surg 1985;72:186-8.
21. [21] Yasui W, Sumiyoshi H, Hata J, Kameda T, Ochiai A, Ito H, Tahara E. Expression of epidermal growth factor receptor in human gastric and colonic carcinoma. Cancer Res 1988;48:137-41.
22. [22] Krueger JG, Krane JF, Carter DM, Gottlieb AB. Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis. J Invest Dermatol 1990;94:135S-40S.
23. [23] Rachel MG, James K, Debra Y, Granelli-Piperno A, Daniel PM, Lester TM, Thomas SK, Pravinkumar BS, Alice BG. Interleukin-6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 1989;86:6367-71.
24. [24] Chang EY, Hammerberg C, Fisher G, Baadsgard O, Ellis CN, Voorhees JJ, Cooper KD. T-cell activation is potentiated by cytokines released by lesional psoriatic, but not normal epidermis. Arch Dermatol 1992;128:1479-85.
25. [25] Ellis CN, Gorsulowsky DC, Hamilton TA. Cyclosporine improves psoriasis and pyoderma gangrenosum treated with FK506. J Invest Dermatol 1991;96:536a (Abstract).
26. [26] Ohta Y, Nishiyama S, Nishioka K. In situ expression of interleukin-6 in psoriatic epidermis during treatment. J Dermatol 1994;21:301-7.
27. [27] Oxholm A, Diamant M, Oxholm P, Bendtzen K. Interleukin-6 in the epidermis of patients with psoriasis before and during PUVA. Acta Derm-Venereol 1989;69:195-9.
28. [28] Elder JT, Sartor CI, Boman DK, Benrazavi S, Fisher GJ, Pittelkow MR. Interleukin-6 in psoriasis: expression and mitogenicity studies. Arch Dermatol Res 1992;284:324-32.
29. [29] Davis S, Aldrich TH, Stahl N, Pan L, Taga T, Kishimoto T, Ip NY, Yancopoulos GD. LIFR β and gpl30 as heterodimerizing signal transducers of tripartite CNTF receptor. Science (Wash. DC) 1993;260:1805-8.
30. [30] Lee F, Chiu C-P, Wideman J, Hodgkin P, Hudak S, Troutt L, Ng T, Moulds C, Coffman R, Zlotnik A, Rennick D. IL-6: a multifunctional regulation of growth and differentiation. Ann New York Acad Sci 1989;557:215-29.
31. [31] Zhang JZ, Maruyama K, Iwatsuki K, Ono I, Kaneko F. Effects of prostaglandin E1 on human keratinocytes and dermal fibroblasts: A possible mechanism for the healing of skin ulcers. Exp Dermatol 1994;3:164-70.
32. [32] Kaneko F, Zhang JZ, Maruyama K, Nihei Y, Ono I, Iwatsuki K, Yamamoto T. Prostaglandin II analogues, SM-10902 and SM-10906, affect human keratinocytes and fibroblasts in vitro in a manner similar to PGE1: therapeutic potential for wound healing. Arch Dermatol Res 1995;287:539-45.
33. [33] Rheinwald JG, Green H. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975;6:331-44.
34. [34] Hirota S, Ito A, Morii E, Wanaka A, Tohyama M, Kitamura Y, Nomura S. Localization of mRNA for c-kit receptor and its ligand in the brain of adult rats: an analysis using in situ hybridization. Mol Brain Res 1992;15:47-54.
35. [35] Motohashi H, Igarashi K, Onodera K, Takahashi S, Ohtani H, Nakafuku M, Nishizawa M, Engel JD, Yamamoto M. Mesodermal-vs. neuronal-specific expression of Mafk is elicited by different promotes. Genes to Cells 1996;1:223-38.
36. [36] Sakai Y, Nelson KG, Snedeker S, Bossert NL. Walker MP, McLachlan J, DiAugustine RP. Expression of epidermal growth factor in suprabasal cells of stratified squamous epithelia: implications for a role in differentiation. Cell Growth Differ 1994;5:527-35.
37. [37] Krane JF, Murphy DP, Martin C, Krueger JG. Synergistic effects of epidermal growth factor (EGF) and insulin-like growth factor I/somatomedin C (IGF-I) on keratinocyte proliferation may be mediated by IGF-I transmodulation of the EGF receptor. J Invest Dermatol 1991;96:419-24.
38. [38] Elder JT, Fisher GJ, Lindquist PB, Bennet GL, Pittelkow MR, Coffey RJ Jr., Ellingsworth L, Derynck R, Voorhees JJ. Overexpression of transforming growth factor in psoriatic epidermis. Science (Wash. DC) 1989;243:811-4.
39. [39] Robert J, Coffey RJ Jr., Rik D, Josiah NW, Timothy SB, Goustin AS, Harold EM, Mark RP. Production and auto-induction of transforming growth factor in human keratinocytes. Nature (Lond.) 1987;27:817-20.
40. [40] Michael P, Christine L, Greg P. Amphiregulin-dependent proliferation of cultured human keratinocytes: autocrine growth, the effects of exogenous recombinant cytokine, and apparent requirement for heparin-like glycosaminoglycans. J Cuta Physiol 1994;159:114-20.